News
The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in the position.
The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
FDA Commissioner Marty A. Makary, M.D., M.P.H. stated, “These CEO Forums are a chance for the FDA to listen and gather feedback from those at the front lines of discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results